HRP20110604T1 - Derivat 4-(3-benzoilaminofenil)-6,7-dimetoksi-2-metilaminokinazolina - Google Patents

Derivat 4-(3-benzoilaminofenil)-6,7-dimetoksi-2-metilaminokinazolina Download PDF

Info

Publication number
HRP20110604T1
HRP20110604T1 HR20110604T HRP20110604T HRP20110604T1 HR P20110604 T1 HRP20110604 T1 HR P20110604T1 HR 20110604 T HR20110604 T HR 20110604T HR P20110604 T HRP20110604 T HR P20110604T HR P20110604 T1 HRP20110604 T1 HR P20110604T1
Authority
HR
Croatia
Prior art keywords
dimethoxy
salt
hydrate
compound
methylaminoquinazolin
Prior art date
Application number
HR20110604T
Other languages
English (en)
Croatian (hr)
Inventor
Miyazaki Kazuki
Kusano Kazutomi
Takase Yasutaka
Asano Osamu
Shirato Manabu
Wakita Hisashi
Ishii Naoto
Saeki Takao
Original Assignee
Eisai R&D Management Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2007/053066 external-priority patent/WO2007097317A1/ja
Application filed by Eisai R&D Management Co. filed Critical Eisai R&D Management Co.
Publication of HRP20110604T1 publication Critical patent/HRP20110604T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20110604T 2006-02-21 2011-08-12 Derivat 4-(3-benzoilaminofenil)-6,7-dimetoksi-2-metilaminokinazolina HRP20110604T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21
PCT/JP2007/053066 WO2007097317A1 (ja) 2006-02-21 2007-02-20 4-(3-ベンゾイルアミノフェニル)-6,7-ジメトキシ-2-メチルアミノキナゾリン誘導体

Publications (1)

Publication Number Publication Date
HRP20110604T1 true HRP20110604T1 (hr) 2011-09-30

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110604T HRP20110604T1 (hr) 2006-02-21 2011-08-12 Derivat 4-(3-benzoilaminofenil)-6,7-dimetoksi-2-metilaminokinazolina

Country Status (18)

Country Link
JP (1) JP4778550B2 (xx)
KR (1) KR101278852B1 (xx)
AT (1) ATE517875T1 (xx)
BR (1) BRPI0708098B8 (xx)
CY (1) CY1112554T1 (xx)
DK (1) DK1992622T3 (xx)
ES (1) ES2368089T3 (xx)
HK (1) HK1122025A1 (xx)
HR (1) HRP20110604T1 (xx)
IL (1) IL193322A (xx)
JO (1) JO2726B1 (xx)
MY (1) MY146275A (xx)
NZ (1) NZ569936A (xx)
PT (1) PT1992622E (xx)
RS (1) RS51969B (xx)
RU (1) RU2431632C2 (xx)
SI (1) SI1992622T1 (xx)
TW (1) TWI404709B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008099887A1 (ja) 2007-02-16 2008-08-21 Eisai R & D Management Co., Ltd. メチル n-[3-(6,7-ジメトキシ-2-メチルアミノキナゾリン-4-イル)フェニル]テレフタラミックアシッドの結晶、非晶質体または塩
EP2189450B1 (en) 2007-08-17 2011-12-21 Eisai R&D Management Co., Ltd. Method for producing quinazoline derivative
JP5060561B2 (ja) 2007-08-17 2012-10-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規外用剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬

Also Published As

Publication number Publication date
RU2431632C2 (ru) 2011-10-20
RS51969B (en) 2012-02-29
PT1992622E (pt) 2011-09-19
HK1122025A1 (xx) 2009-05-08
TW200812980A (en) 2008-03-16
SI1992622T1 (sl) 2011-11-30
KR20080094811A (ko) 2008-10-24
CY1112554T1 (el) 2016-02-10
TWI404709B (zh) 2013-08-11
DK1992622T3 (da) 2011-09-05
MY146275A (en) 2012-07-31
IL193322A (en) 2014-04-30
BRPI0708098B8 (pt) 2021-05-25
JO2726B1 (en) 2013-09-15
ES2368089T3 (es) 2011-11-14
KR101278852B1 (ko) 2013-07-01
JP4778550B2 (ja) 2011-09-21
BRPI0708098B1 (pt) 2019-08-06
ATE517875T1 (de) 2011-08-15
NZ569936A (en) 2010-07-30
IL193322A0 (en) 2009-05-04
BRPI0708098A2 (pt) 2011-05-17
RU2008137654A (ru) 2010-03-27
JPWO2007097317A1 (ja) 2009-07-16

Similar Documents

Publication Publication Date Title
HRP20140011T1 (hr) Derivati oksazina i njihova uporaba u lijeäśenju neuroloških poremeä†aja
HRP20130976T1 (hr) Karbonilaminopirolopirazoli, potentni inhibitori kinaza
ECSP10010336A (es) Derivados de piridina
HRP20161657T1 (hr) Kinazolinoni kao inhibitori humane fosfatidilinozitol 3- kinaze delta
HRP20180425T1 (hr) Čvrste kompozicije koje sadrže agonist glp-1 i sol n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline
HRP20161408T1 (hr) Cefalosporin koji sadrži katehol skupinu
BRPI0507877A (pt) derivados de formamida, composição farmacêutica, uso dos mesmos e combinação
HRP20220003T1 (hr) Spojevi derivata 1,3,4-oksadiazola kao inhibitori histonske deacetilaze 6, i farmaceutski pripravak koji ih sadrži
BRPI0512985A (pt) derivados de 3-carbamoil-2-piridona
HRP20120963T1 (hr) PIRIDO-, PIRAZO- I PIRIMIDOPIRIMIDINSKI DERIVATI KAO mTOR INHIBITORI
HRP20171793T1 (hr) Farmaceutske formulacije koje sadrže kristalne oblike (r)-7-kloro-n-(kinuklidin-3-il)benzo(b)tiofen-2-karboksamid hidroklorid monohidrata
RS51973B (en) STABLE PHARMACEUTICAL PRODUCTS CONTAINING FEZOTERODINE
BR112013003581A2 (pt) formulação farmacêutica ou nutracêutica gastro resistente que compreende um ou mais sais do ácido algínico
CL2007003260A1 (es) Compuestos derivados de azabiciclo[2.2.2]octano; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedad pulmonar obstructiva cronica.
BRPI0607308A2 (pt) compostos, composições farmacêuticas e usos dos referidos compostos
SI2303270T1 (en) Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceutical products
HRP20211762T1 (hr) Derivati benzoksaborola za liječenje bakterijskih infekcija
HRP20180196T1 (hr) Diketoni i hidroksiketoni kao aktivatori puta signalizacije katenina
HRP20110604T1 (hr) Derivat 4-(3-benzoilaminofenil)-6,7-dimetoksi-2-metilaminokinazolina
HRP20120957T1 (hr) Stabilni farmaceutski sastav koji sadrži pirimidin-sulfamid
FR2903107B1 (fr) Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
BR112012032358A2 (pt) processo para a preparação de dronedarona
JP2015525763A5 (xx)
SI2760821T1 (en) A salt salt of an anti-inflammatory substituted cyclobutenedione compound
JP2011500621A5 (xx)